Dinalbuphine sebacate
Dinalbuphine sebacate is a pharmaceutical drug with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Dinalbuphine Sebacate in Postoperative Pain Control After TKA
Postoperative Pain Management of Caesarean Section
Postoperative Pain Management on Patients Undergoing Lung Tumor Resection
Postoperative Pain Management on Uvulopalatopharyngoplasty Patients
Naldebain® Extended-release Injection After Cesarean Section in Pain Management
Clinical Trials (8)
Dinalbuphine Sebacate in Postoperative Pain Control After TKA
Postoperative Pain Management of Caesarean Section
Postoperative Pain Management on Patients Undergoing Lung Tumor Resection
Postoperative Pain Management on Uvulopalatopharyngoplasty Patients
Naldebain® Extended-release Injection After Cesarean Section in Pain Management
Naldebain for Pain Management of Laparoscopic Cholecystectomy
Naldebain for Pain Control After Bariatric Surgery
A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8